GeneDx Holdings Corp.

WGS
$67.51 (- $4.20 - 5.86%)
Last updated: 2026-07-04 04:55 UTC
WGS Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryDiagnostics & Research
ISINUS81663L2007
CUSIP81663L200
Market Price67.51
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio1216.27
EPS0.11
Market Cap$3.9B
Book Value10.12
Price to Book13.226
Beta2.04
52w High170.87
52w Low55.17
Next Earnings DateN/A

GeneDx Holdings Corp. trades under ticker WGS on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US81663L2007, CUSIP 81663L200.

About the Company
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
Price History